PDT Partners’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,846
Closed -$571K 671
2022
Q4
$571K Sell
16,846
-3,684
-18% -$125K 0.09% 360
2022
Q3
$985K Sell
20,530
-34,970
-63% -$1.68M 0.15% 222
2022
Q2
$3.16M Buy
55,500
+11,978
+28% +$683K 0.28% 76
2022
Q1
$3.52M Buy
43,522
+35,835
+466% +$2.9M 0.3% 72
2021
Q4
$1.56M Sell
7,687
-785
-9% -$159K 0.12% 274
2021
Q3
$2.28M Sell
8,472
-2,792
-25% -$752K 0.16% 232
2021
Q2
$2.9M Buy
11,264
+330
+3% +$84.9K 0.19% 224
2021
Q1
$3.28M Sell
10,934
-1,319
-11% -$396K 0.24% 179
2020
Q4
$3.13M Buy
12,253
+575
+5% +$147K 0.21% 200
2020
Q3
$2.91M Sell
11,678
-727
-6% -$181K 0.19% 175
2020
Q2
$4.31M Sell
12,405
-9,114
-42% -$3.17M 0.29% 130
2020
Q1
$5.76M Sell
21,519
-5,299
-20% -$1.42M 0.46% 77
2019
Q4
$8.68M Sell
26,818
-3,340
-11% -$1.08M 0.54% 71
2019
Q3
$8.24M Buy
30,158
+15,120
+101% +$4.13M 0.49% 74
2019
Q2
$8.03M Buy
+15,038
New +$8.03M 0.47% 83
2017
Q3
Sell
-44,300
Closed -$13M 551
2017
Q2
$13M Buy
44,300
+13,160
+42% +$3.86M 0.52% 46
2017
Q1
$11M Buy
31,140
+14,727
+90% +$5.18M 0.57% 31
2016
Q4
$3.02M Buy
16,413
+2,826
+21% +$520K 0.2% 192
2016
Q3
$3.5M Buy
13,587
+47
+0.3% +$12.1K 0.2% 174
2016
Q2
$2.89M Hold
13,540
0.23% 164
2016
Q1
$2.79M Buy
13,540
+4,787
+55% +$987K 0.17% 207
2015
Q4
$2.21M Buy
+8,753
New +$2.21M 0.3% 143
2014
Q3
Sell
-4,387
Closed -$844K 1494
2014
Q2
$844K Sell
4,387
-1,950
-31% -$375K 0.02% 761
2014
Q1
$1.15M Sell
6,337
-2,133
-25% -$388K 0.03% 633
2013
Q4
$1.44M Sell
8,470
-14,320
-63% -$2.44M 0.17% 163
2013
Q3
$3.57M Buy
22,790
+6,313
+38% +$989K 0.1% 271
2013
Q2
$2.86M Buy
+16,477
New +$2.86M 0.07% 388